← Back

Criteria Capital Risc | Criteria Bio Ventures

vc$300MCo-investsLeads rounds

Fund Size

$300M

Check Size

$1.0M$10.0M

Location

Spain

Portfolio

10 companies

Activity

Statusactively investing

Links

Share this fund

Investment Thesis

Identifying, financing and supporting innovative companies developing new therapies with the potential to transform treatment of diseases and improve people's lives.

About Criteria Capital Risc

Criteria Bio Ventures is the evergreen Life Sciences venture capital arm of CriteriaCaixa, dedicated to investments in the Life Sciences. With over 20 years of VC experience, we leverage our strong legacy and commitment to society and healthcare to support innovative companies that are tackling vital therapeutic challenges.

Sectors

BiotechDrug DiscoveryDiagnosticsDigital HealthMedtech

Stages

pre-seedseed

Geography Focus

EuropeNorth AmericaPortugalSpain

Team

NameTitleRoleLinks
Pablo CironiDirectorSenior
Alejo ChornyPrincipalMid
Beltrán VivesIn-house LawyerMid
Juan-Pablo BartraFinance Operations ManagerMid
Marcelino ArmenterChairmansenior
Mireia PasalamarManagement AssistantJunior
Salvatore CappadonaPrincipalMid
Sebastián ChiavennaPrincipalMid

Notable Investments

Northern BiologicsMinoryx TherapeuticsAboleris PharmaSanifit Therapeutics8LayersCytospire TherapeuticsAdaptam TherapeuticsNRG TherapeuticsTolerance BioNanusens

Traits

Leads rounds

Co-invests

FAQ

What does Criteria Bio Ventures invest in?

Criteria Bio Ventures invests in Biotech, Drug Discovery, Diagnostics, Digital Health and Medtech at the pre-seed and seed stages.

Which geographies does Criteria Bio Ventures focus on?

Criteria Bio Ventures focuses on Europe, North America, Portugal and Spain, and is headquartered in Spain.

What is Criteria Bio Ventures's typical check size?

Criteria Bio Ventures typically writes checks of $1M to $10M.